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Summary
Pentacyclic triterpenes are a group of compounds known to have anticancer activity. One of 
the best characterized triterpenes is betulin, which can be isolated from bark of birch trees 
and modified into new compounds with various interesting medical properties. Betulin is in-
volved in activation of the caspase cascade and promotes cell death. The aim of the study was 
to investigate the effect of betulin and its acetylenic derivative, 28-O-propynoylbetulin, on 
proliferation and apoptosis in a human melanoma cell line.
The G-361 melanoma cell line was used. To evaluate growth arrest and caspase-3 activity, cells 
were treated with betulin and its derivative at a wide range of concentrations from 0.1 to 10 
µg/mL. 
Betulin and 28-O-propynoylbetulin inhibited cell proliferation in a concentration-dependent 
manner. The cell cycle analysis revealed an increase of the sub-G1 cell fraction (representing 
dead cells) after incubation of cells with betulin and 28-O-propynoylbetulin. The observed 
cytotoxic effects were more pronounced for 28-O-propynoylbetulin. Activity of caspase-3 in 
28-O-propynoylbetulin treated cells was nearly 2-fold greater compared to cells incubated 
with betulin. 
Our results show that betulin and 28-O-propynoylbetulin were effective in inhibition of cell 
growth and induction of apoptosis in a human melanoma cell line. The addition of the pro-
pynoyl group at the C-28 hydroxyl group of betulin led to a greater proapoptotic and anti-
proliferative effect in comparison to unmodified betulin. These observations suggest that the 
obtained derivative is a potent anti-melanoma agent. 
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IntroductIon
In 2012, there were at least 100,300 new cases of mali-
gnant melanoma in Europe. Malignant melanoma inci-
dence and mortality are constantly rising [12]. The most 
common risk factors include exposure to UV radiation, 
fair skin, dysplastic nevi syndrome, age and family hi-
story. In view of the significant treatment resistance, co-
nventional therapy strategies are insufficient. Therefore, 
there is a great demand for more effective anti-melanoma 
agents [11,16,20]. It has been discovered that a group of 
natural compounds called triterpenes, widely distribu-
ted in nature, has potential anti-cancer activity [16,18]. 
Betulin [lup-20(29)-ene-3β,28-diol, 1] is a pentacyclic lu-
pane-type triterpene alcohol found in the bark of birch 
trees [29]. Betulin (1) can be easily isolated from the plant 
material but it has limited solubility in aqueous media. 
Fortunately, it can be easily converted into more solu-
ble derivatives such as betulinic acid (2) and others. The 
chemical modifications of betulin (1) can be done within 
the secondary hydroxyl group at position C-3, primary 
hydroxyl group at C-28 and alkene moiety at position 
C-20 [8,23,24]. 
A number of studies have been reported describing an-
tiviral, antibacterial, antimalarial, hepatoprotective and 
anti-inflammatory activities of betulin derivatives [15,30]. 
Recent data have described the anti-HIV activity after 
application of these compounds. Extensive studies indi-
cated that they can act as e.g. membrane fusion or virus 
maturation inhibitors. Betulin (1) and its derivatives in-
duced apoptosis in various cancer cell types, including 
glioblastoma, leukaemia and lung carcinoma [1,3]. Betulin 
(1) is involved in the mitochondria-mediated caspase-9 
activation pathway (intrinsic pathway of apoptosis) by 
triggering Bak and Bax translocation which results in 
depolarization of the mitochondrial membrane poten-
tial. These processes result in the release of cytochrome 
c and proapoptotic proteins into the cytosol followed by 
activation of the caspase cascade (-9, -3, -7) and cell death 
[19,20]. Betulin derivatives are also involved in triggering 
cancer cell death. 
Betulin (1) can bind to the cell membrane melanocortin 
receptor (subtype MC1) in mouse melanoma cells. MC1 
receptors are expressed mainly in skin, melanoma and 
immune cells. They belong to G-protein-coupled recep-
tors and are involved in cAMP generation. Betulin (1) 
connection with MC1 receptor antagonizes α-melanocyte 
stimulating hormone and leads to inhibition of cAMP syn-
thesis. On the one hand, α-MSH can act as a metastasis 
blocker (reducing cell migration and invasion) but on the 
other, it can reduce the ability of immune cells to detect 
tumour cells (downregulation of the expression of adhe-
sion molecules). The role of α-MSH and cAMP needs to 
be more thoroughly investigated but it has been shown 
that the higher the density of MC1 receptors, the greater 
is cAMP production in human melanoma cells [22,28].
The aim of the study was to investigate the effect of betu-
lin (1) and its derivative called 28-O-propynoylbetulin (3) 
(Fig. 1) on proliferation and apoptosis in the G-361 human 
melanoma cell line. 
MaterIals and Methods
Chemicals
Betulin (1) with a purity of ≥98% was purchased from Sig-
ma-Aldrich. 28-O-Propynoylbetulin (3) was synthesized 
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– Bcl2-antagonist/killer, Bax – Bcl-2–associated X protein, cAMP – adenosine 3’,5’,-cyclic monophos-
phate, MC-1 – cell membrane melanocortin receptor 1, NaB – sodium butyrate, PI – propidium 
iodide, pNA – p-nitroaniline.
Fig. 1.  Chemical structure of betulin (1), betulinic acid (2) and 
28-O-propynoylbetulin (3)193
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via esterification of the C-28 hydroxyl group of betulin (1) 
with propynoic acid and characterized by standard spec-
troscopic methods. The 1H-NMR, 13C-NMR, IR and MS (EI) 
spectral data of compound 3 were reported in the litera-
ture by Boryczka [4].
Cells
The malignant melanoma G-361 cell line was purchased from 
LGC Promochem (Łomianki, Poland). It was obtained from 
the skin of 31-year-old male patient. The cells were grown in 
medium containing the following composition: 90% McCoy’s 
medium (Sigma-Aldrich), 10% fetal bovine serum (PAA), 100
U/mL penicillin, 100 μg/mL streptomycin (Sigma-Aldrich), 
and 10 mM HEPES (Sigma-Aldrich). The cells were cultivat-
ed at 37°C in a humidified atmosphere containing 5% CO2. 
Cell proliferation 
To assess cell proliferation, the “In Vitro Toxicology As-
say Kit, Sulforhodamine B Based” (Sigma-Aldrich) was 
used. Cells were seeded at an initial density of 103 cells 
per well in 200 µl of culture medium in 96-well plates. Af-
ter 24 hours of incubation, test reagents – betulin (1) and 
28-O-propynoylbetulin (3) – were added for the next 72 
hours. The range of concentrations for both reagents was 
from 0.1 to 10 µg/mL. At the end of the incubation period, 
cells were washed with phosphate-buffered saline (PBS, 
Sigma-Aldrich), fixed in trichloroacetic acid (10% TCA) and 
stained with sulforhodamine B. After dissolution of the in-
corporated dye, absorbance was measured at 570 nm and 
690 nm (reference wavelength) using the MRX Revelation 
plate reader (Dynex Technologies).
Cell cycle analysis
To study the cell cycle, G-361 cells were plated at an initial 
density of 106 cells per 100-mm diameter dish in 15  mL of 
culture medium. Cells were allowed to attach and grow for 
24 hours prior to exposure to test reagents. Cells were incu-
bated with compounds 1 and 3 (both at concentrations of 3 
µg/mL and 10 µg/mL) for 48 hours. Control cultures were 
treated with vehicle (0.2% DMSO). Sodium butyrate (NaB) at 
a concentration of 1 mM was used as a positive control. NaB 
is known to block cell cycle progression in G1 and G2 phases. 
After 48 hours cells were trypsinized and washed twice 
with ice-cold PBS, filtered (20 µm Syringe Filcons Non-
Sterile, BD Biosciences) and fixed in 70% ice-cold ethanol 
while vortexing at low speed. The samples were stored at 
4°C overnight. Directly before the assay, cells were treated 
with RNase A (10 mg/ml, Sigma-Aldrich, for 1 hour at 
37°C), stained with propidium iodide (PI, Calbiochem, 
1 mg/ml) and then analysed in a flow cytometer (FACS 
AriaII, Becton Dickinson). DNA histograms were exam-
ined with BD FACSDiva software (Becton Dickinson) and 
showed the distribution of cells in cell cycle phases. Ad-
ditionally, the amount of polyploids was estimated.
Caspase-3 activity
To determine the proapoptotic caspase-3 activity, the 
“Caspase-3 Assay Kit, Colorimetric” (Sigma-Aldrich) was 
used. Cells were plated at the density of 106 per 100-mm 
diameter dish and incubated in standard medium for 24 
hours. The investigated reagents (1, 10 µg/mL and 3, 10 
µg/mL) were added for the next 24 hours. After this pe-
riod, cells were scraped from the dishes and lysed. Cell 
lysates were centrifuged (16000 g; 10 min) and stored at 
-80°C. The assay is based on hydrolysis of the substra-
te, Ac-DEVD-pNA (acetyl-Asp-Glu-Val-Asp-pNA), by ac-
tive caspase-3. The absorbance of released p-nitroaniline 
(pNA) was measured at 405 nm using the MRX Revelation 
plate reader (Dynex Technologies). Results are expressed 
relative to cellular protein content, which was determi-
ned spectrophotometrically by Bradford’s method [6].
results
Cell proliferation 
In order to elucidate the influence of tested compounds on 
cell proliferation, cells were incubated in the presence of 
various concentrations (0.1, 0.3, 1, 3, 10 µg/mL) of betulin 
(1) and compound 3. The effect of 72 hours of incubation 
is shown in Fig. 2. The lowest concentrations (0.1 and 0.3 
Fig. 2.  Growth of G-361 cell line cultured in the presence of various concentrations of betulin (1) (A) and 28-O-propynoylbetulin (3) (B). Each bar represents the 
mean ± SD; *p < 0.05 compared with control194
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µg/mL) of both reagents did not cause a significant change 
in the cell growth rate, compared to the control group. In 
comparison to 1 µg/mL betulin (1), treatment with deriva-
tive 3 at 1 µg/mL resulted in a significant reduction of the 
cell proliferation. At concentrations above 1 µg/mL, both 
tested substances caused concentration-dependent inhibi-
tion of cell growth. 28-O-Propynoylbetulin (3) and betulin 
(1) maximally inhibited cell proliferation when added to 
the cells at a concentration of 10 µg/mL.
Cell cycle analysis
As shown in Fig. 3, exposure of G-361 cells to the tested 
compounds for 48 hours resulted in alterations in the cell 
cycle phase distribution. Under control conditions 22.6% 
of the cells were in the S phase (Fig. 3.A). Cell incubation 
with 1 mM NaB, a well-known inhibitor of cell division, 
resulted in a decrease of the percentage of cells in S phase 
to 11.9% (Fig. 3.B). Simultaneously, accumulation of cells 
Fig. 3.  Cell cycle analysis of G-361 cells incubated with B) sodium butyrate (1 mM), C) betulin (1) (3 µg/mL), D) betulin (1) (10 µg/mL), E) 28-O-propynoylbetulin (3) 
(3 µg/mL), F) 28-O-propynoylbetulin (3) (10 µg/mL); A) untreated control cells
Polyploids Polyploids
Polyploids Polyploids
Polyploids Polyploids195
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in both G1 and G2/M phases took place. Additionally, NaB 
caused an increase in the percentage of cells in the sub-
-G1 fraction from 5.0% to 6.8%, indicating some augmen-
tation of cell death. The histograms of G-361 cells treated 
with betulin (1) and derivative 3 revealed large increases 
in the sub-G1 fraction, indicating significant induction of 
cell death (Fig. 3.C-F). The amount of dead cells was con-
centration-dependent and was higher in cultures treated 
with 28-O-propynoylbetulin (3) than in cultures incubated 
with betulin (1). Massive cell death in the cultures treated 
with the highest concentration (10 µg/mL) of compounds 
3 and 1 was also manifested by a significant increase in the 
amount of cells that rounded up, detached from the dish 
and floated in the medium (data not shown). 
Regardless of cell death, betulin (1) seems to arrest the 
cell cycle at G2/M phase. After subtracting the sub-G1 
fraction under control conditions, the percentages of G1, 
S and G2/M phase cells were 56%: 24%: 20%, respectively. 
In cultures treated with compound 1 at concentrations of 
3 µg/mL and 10 µg/mL, the cell cycle phase distributions 
were 58%: 20%: 22% and 55%: 21%: 25%, respectively. Simi-
lar accumulation of cells in G2/M phase was not observed 
in the cultures incubated with compound 3. 
Caspase-3 activity
In order to determine whether the observed cell death 
was apoptotic, the impact of the studied compounds on 
caspase-3 activity in G-361 cells was assayed. Betulin (1) 
and 28-O-propynoylbetulin (3) were used at a concen-
tration of 10 µg/mL and the cells were exposed to the 
compounds for 24 hours. Both substances significantly 
stimulated the enzyme activity compared to the control 
(Fig. 4), however, 3 was a much more powerful inducer 
than betulin (1) (activity of caspase-3 in derivative 3 tre-
ated cells was nearly 2-fold greater compared to cells in-
cubated with betulin (1)). The magnitude of increases of 
enzyme activity was proportional to the number of dead 
(sub-G1) cells determined by flow cytometry. Therefo-
re, we concluded that treatment with substances 1 and 
3 resulted in apoptosis induction in G-361 cell cultures. 
Our results clearly show that betulin (1) and its derivative 
28-O-propynoylbetulin (3) were effective inhibitors of cell 
proliferation and activators of apoptosis in G-361 melano-
ma cell culture. These effects were concentration-depen-
dent and more pronounced for the betulin derivative. The 
low concentrations (0.1-1 µg/mL) of betulin (1) and 28-O-
-propynoylbetulin (3) were insufficient to significantly 
reduce cell growth. The best antiproliferative effect was 
seen at concentrations above 1 μg/mL (3 and 10 μg/mL) 
of both compounds. 
dIscussIon
Malignant melanoma is the most dangerous cutaneous 
cancer. A lot of anti-melanoma therapies including surge-
ry, chemotherapy, immunotherapy, and targeted therapy 
have been developed. The anti-cancer strategies are based 
on elimination of tumour cells by e.g. suppression of cell 
proliferation and induction of apoptosis [2,10]. Apoptosis 
is a result of extrinsic or intrinsic activation pathways. 
In both cases, activation of proapoptotic enzymes called 
caspases ultimately leads to cell death. The most impor-
tant effector caspase is caspase-3, which is responsible 
for chromatin condensation, DNA degradation, protein 
(vimentin, gelsolin, fodrin, poly(ADP-ribose)polymera-
se) cleavage and cell blebbing [26]. In cancer treatment, 
these processes should be promoted only in tumour cells 
without a negative influence on normal cells [32].
Triterpenes are a group of compounds that can suppress cell 
proliferation and stimulate apoptosis. A widely naturally oc-
curring representative of triterpenes is betulin (1). Poor aqu-
eous solubility is the major problem associated with betulin 
(1) administration. It affects penetration of the compound 
into cells. Solving that problem involves the use of betulin 
(1) as a precursor and converting it into betulinic acid (2) and 
other derivatives [25,31]. For years, the majority of studies 
have described compound 1 as an inactive or weakly active 
anti-cancer compound. Hata et al. [14] showed that the lu-
pane triterpenes with a carbonyl group at C-17 had greater 
cytotoxicity to melanoma (SK-MEL-28, G361), leukaemia 
(K562, U937, HL60) and neuroblastoma (NB-1, GOTO) cells 
compared to betulin (1). Further studies by Pyo et al. [27] and 
Gauthier et al. [13] evidenced induction of apoptosis in breast 
(MCF7), lung (A549), prostate (PC-3) and colorectal (DLD-1) 
cancer cells attributed to betulin (1) administration. Li et al. 
[19] revealed that betulin (1) is a stronger cell death inducer 
in human cervix carcinoma HeLa, hepatoma HepG2, breast 
cancer MCF7 and lung adenocarcinoma A549 cells than in 
prostate PC-3, carcinoma NCI-460 and hepatoma SK-HEP-1 
cells. Drag et al. [9] compared the cytotoxic effect of betulin 
(1), betulinic acid (2) and extract from bark of birch tree on 
human gastric carcinoma (EPG85-257) and human pancre-
atic carcinoma (EPP85-181) drug-sensitive and drug-resi-
stant cell lines. Although betulin (1) was the least active of 
all compounds, the results indicated that betulin (1) had a 
good inhibitory concentration value (IC50) and had a signifi-
cant cytotoxic impact on pancreatic and gastric carcinoma 
drug-resistant cell lines. 
Fig. 4.  The effect of 24 hours of exposure to 10 µg/mL betulin (1) and 10 µg/
mL 28-O-propynoylbetulin (3) on caspase-3 activity in G-361 cells. Each 
bar represents the mean ± SD; *p < 0.05 compared with control196
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In the present study, the G-361 melanoma cell line was 
used to assess the antiproliferative and proapoptotic pro-
perties of betulin (1) and its acetylenic derivative 28-O-
-propynoylbetulin (3). This betulin derivative was chosen 
on the basis of a preliminary study that revealed its acti-
vity against melanoma cells (data not shown). The intro-
duction of an alkyne motif into the betulin structure (the 
carbon-carbon triple bond) may have a significant influ-
ence on biological properties of the compound [5]. The 
28-O-Propynoylbetulin (3) was obtained by addition of a 
propynoyl group to betulin (1) at the C-28 position. Bo-
ryczka et al. [4] have previously observed that compound 
3 was the strongest cytotoxic agent against human leu-
kaemia (CCRF/CEM) and murine leukaemia (P388) when 
compared to its precursor, other acetylenic betulins and 
cisplatin. 28-O-Propynoylbetulin (3) was less active aga-
inst breast cancer (T47D) and colorectal cancer (SW707). 
In our study, we confirmed the ability of both compounds 
1 and 3 to induce cell growth arrest and apoptosis. Li et 
al. [19] investigated the anti-cancer activity of betulin (1) 
in HeLa cells. Betulin (1) at 10 µg/mL induced apoptosis 
in HeLa cells e.g. via caspase-3 activation. 
In our study, treatment of G-361 cells with betulin (1) 
resulted in significant caspase-3 activation. However, in-
cubation of cells with 28-O-propynoylbetulin (3) led to 
apoptosis induction at a significantly higher level than 
with betulin (1) (nearly 2-fold greater). The flow cyto-
metry analysis detected a considerable increase of the 
sub-G1 cell fraction after incubation with tested compo-
unds and the percentage of sub-G1 cells corresponded 
well with activity of caspase-3 (higher for compound 3 
and lower for betulin (1)). 
Betulin and betulinic acid are believed to exert their cy-
totoxic effects primarily through the interaction with 
mitochondrial membrane, resulting in its increased per-
meability, the release of mitochondrial cytochrome c or 
apoptosis-inducing factor (AIF) into the cytosol and the 
activation of caspases, leading to apoptotic cell death 
[7,19]. Our findings showed that addition of the propy-
noyl group at the C-28 hydroxyl group of betulin (1) leads 
to a stronger proapoptotic effect and cell growth arrest 
in comparison to betulin (1). In that derivative, the ter-
minal triple bond is located close to the carbonyl group, 
forming a relatively reactive configuration [4]. We sup-
pose that the interaction of the propynoyl group with 
nucleophilic amine and thiol groups augments a distur-
bance of the mitochondrial membrane integrity leading 
to decreased cell viability. The obtained derivative seems 
to be a potent anti-cancer agent with concentration-de-
pendent activity. The cytotoxic effect of betulin (1) and its 
acetylenic derivative 3 on melanoma cells has to be more 
carefully examined. Exploiting the mechanism of action 
of the analysed compounds may aid in development of 
new anti-melanoma strategies. 
[1] Alakurtti S., Mӓkelӓ T., Koskimies S., Yli- Kauhaluoma J.: Phar-
macological properties of the ubiquitous natural product betulin. 
Eur. J. Pharm. Sci., 2006; 29: 1-13
[2] Bhatia S., Tykodi S.S., Thompson J.A.: Treatment of metastatic 
melanoma: an overview. Oncology, 2009; 23: 488-496
[3] Bori I.D., Hung H.Y., Qian K., Chen C.H., Morris-Natschke S.L., 
Lee K.H.: Anti-AIDS agents 88. Anti-HIV conjugates of betulin and 
betulinic acid with AZT prepared via click chemistry. Tetrahedron 
Lett., 2012; 53: 1987-1989
[4] Boryczka S., Bębenek E., Wietrzyk J., Kempińska K., Jastrzębska 
M., Kusz J., Nowak M.: Synthesis, structure and cytotoxic activity of 
new acetylenic derivatives of betulin. Molecules, 2013; 18: 4526-4543
[5] Boryczka S., Mól W., Milczarek M., Wietrzyk J., Bębenek E.: Synthesis 
and in vitro antiproliferative activity of novel (4-chloro- and 4- acyl-
oxy-2-butynyl)thioquinolines. Med. Chem. Res., 2011; 20: 1402-1410
[6] Bradford M.M.: A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the principle of 
protein-dye binding. Anal. Biochem., 1976; 72: 248-254
[7] Chen Y., Sun R., Wang B.: Monolayer behavior of binary systems 
of betulinic acid and cardiolipin: thermodynamic analyses of Lang-
muir monolayers and AFM study of Langmuir-Blodgett monolayers. 
J. Colloid Interface Sci., 2011; 353: 294-300
[8] Dehelean C.A., Soica C., Ledeti I., Aluas M., Zupko I., Luscan A., 
Cinta-Pinzaru S., Munteanu M.: Study of the betulin enriched birch 
bark extracts effects on human carcinoma cells and ear inflamma-
tion. Chem. Cent. J., 2012; 6: 137
[9] Drag M., Surowiak P., Drag-Zalesinska M., Dietel M., Lage H., Olek-
syszyn J.: Comparision of the cytotoxic effects of birch bark extract, 
betulin and betulinic acid towards human gastric carcinoma and 
pancreatic carcinoma drug-sensitive and drug-resistant cell lines. 
Molecules, 2009; 14: 1639-1651
[10] Eggermont A.M., Robert C.: New drugs in melanoma: it’s a whole 
new world. Eur. J. Cancer, 2011; 47: 2150-2157
[11] Erdmann F., Lortet-Tieulent J., Schüz J., Zeeb H., Greinert R., 
Breitbart E.W., Bray F.: International trends in the incidence of ma-
lignant melanoma 1953-2008 - are recent generations at higher or 
lower risk? Int. J. Cancer, 2013; 132: 385-400
[12] Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coe-
bergh J.W., Comber H., Forman D., Bray F.: Cancer incidence and 
mortality patterns in Europe: estimates for 40 countries in 2012. 
Eur. J. Cancer, 2013; 49: 1374-1403
[13] Gauthier C., Legault J., Lavoie S., Rondeau S., Tremblay S., Pi-
chette A.: Synthesis and cytotoxicity of bidesmosidic betulin and 
betulinic acid saponins. J. Nat. Prod., 2009; 72: 72-81
[14] Hata K., Hori K., Takahashi S.: Differentiation- and apoptosis-
inducing activities by pentacyclic triterpenes on a mouse melanoma 
cell line. J. Nat. Prod., 2002; 65: 645-648
[15] Jäger S., Laszczyk M.N., Scheffler A.: A preliminary pharma-
cokinetic study of betulin, the main pentacyclic triterpene from 
extract of outer bark of birch (Betulae alba cortex). Molecules, 2008; 
13: 3224-3235
[16] Jäger S., Trojan H., Kopp T., Laszczyk M.N., Scheffler A.: Pentacy-
clic triterpene distribution in various plants – rich sources for a new 
group of multi-potent plant extracts. Molecules, 2009; 14: 2016-2031
[17] Joshua A.M.: Melanoma prevention: are we doing enough? A 
Canadian perspective. Curr. Oncol., 2012; 19: e462-e467
references197
Orchel A. et al. – Influence of betulin and 28-O-propynoylbetulin...
[18] Laszczyk M.N.: Pentacyclic triterpenes of the lupane, oleanane 
and ursane group as tools in cancer therapy. Planta Med., 2009; 75: 
1549-1560
[19] Li Y., He K., Huang Y., Zheng D., Gao C., Cui L., Jin Y.H.: Betulin 
induces mitochondrial cytochrome c release associated apoptosis 
in human cancer cells. Mol. Carcinog., 2010; 49: 630-640
[20] Li Y., Shen J.T., Gao C., Li Q., Jin Y.H.: Caspase-9 activation - criti-
cal for betulin-induced apoptosis of human hepatoma cells. Chem. 
Res. Chin. Univ., 2010; 26: 792-797
[21] MacKie R.M., Hauschild A., Eggermont A.M.: Epidemiology of in-
vasive cutaneous melanoma. Ann. Oncol., 2009, 20 (Suppl. 6): vi1-vi7
[22] Muceniece R., Saleniece K., Riekstina U., Krigere L., Tirzitis G., 
Ancans J.: Betulin binds to melanocortin receptors and antagoniz-
es α-melanocyte stimulating hormone induced cAMP generation 
in mouse melanoma cells. Cell Biochem. Funct., 2007; 25: 591-596
[23] Mukherjee R., Kumar V., Srivastava S.K., Agarwal S.K., Burman 
A.C.: Betulinic acid derivatives as anticancer agents: structure ac-
tivity relationship. Anticancer Agents Med. Chem., 2006; 6: 271-279
[24] Mullauer F.B., Kessler J.H., Medema J.P.: Betulin is a potent anti-
tumor agent that is enhanced by cholesterol. PLoS One, 2009; 4: e1
[25] Patočka J.: Biologically active pentacyclic triterpenes and their 
current medicine signification. J. Appl. Biomed., 2003; 1: 7-12
[26] Porter A.G., Jänicke R.U.: Emerging roles of caspase-3 in apop-
tosis. Cell Death Differ., 1999; 6: 99-104
[27] Pyo J.S., Roh S.H., Kim D.K., Lee J.G., Lee Y.Y., Hong S.S., Kwon 
S.W., Park J.H.: Anti-cancer effect of betulin on a human lung can-
cer cell line: a pharmacoproteomic approach using 2 D SDS PAGE 
coupled with nano-HPLC tandem mass spectrometry. Planta Med., 
2009; 75: 127-131
[28] Quinn T., Zhang X., Miao Y.: Targeted melanoma imaging and 
therapy with radiolabeled alpha-melanocyte stimulating hormone 
peptide analogues. G. Ital. Dermatol. Venereol., 2010; 145: 245-258
[29] Soica C., Dehelean C., Danciu C., Wang H.M., Wenz G., Ambrus R., 
Bojin F., Anghel M.: Betulin complex in γ-cyclodextrin derivatives: 
properties and antineoplasic activities in in vitro and in vivo tumor 
models. Int. J. Mol. Sci., 2012; 13: 14992-15011
[30] Suresh C., Zhao H., Gumbs A., Chetty C.S., Bose H.S.: New ionic 
derivatives of betulinic acid as highly potent anti-cancer agents. 
Bioorg. Med. Chem. Lett., 2012; 22: 1734-1738
[31] Tan Y., Yu R., Pezzuto J.M.: Betulinic acid-induced programmed 
cell death in human melanoma cells involves mitogen-activated pro-
tein kinase activation. Clin. Cancer Res., 2003; 9: 2866-2875
[32] Viola J.R., Rafael D.F., Wagner E., Besch R., Ogris M.: Gene therapy 
for advanced melanoma: selective targeting and therapeutic nucleic 
acids. J. Drug Deliv., 2013; 2013: 897348
The authors have no potential conflicts of interest to declare.